These important data from our long-time SALSAmigos Rumenapf and Morbach and coworkers from Duesseldorf. Summary: Background: With growing prevalence, end-stage renal disease (ESRD) as well as critical limb ischemia (CLI) are both conditions associated with high morbidity and mortality rates. Patients and methods: A retrospective single-centre study provided data of a German interdisciplinary vascular centre. […]Read More Outcomes of severe limb ischemia with tissue loss and impact of revascularization in hemodialysis patients with wound, ischemia, and foot infection (WIFI) stage 3 or 4
Yet more data supporting the use of procalcitonin as a marker for lower extremity infection. This time, from our SALSAmigos Luigi Uccioli and coworkers from Abano Terme. We post a couple of helpful tables above from other manuscripts. Aim:To evaluate the prognostic role of procalcitonin (PCT) in patients with diabetic foot infection (DFI) and critical […]Read More Procalcitonin Is a Prognostic Marker of Hospital Outcomes in Patients with Critical Limb Ischemia and Diabetic Foot Infection #DiabeticFoot
Great work from our long-time SALSAmigos at UTSW in Dallas led by Prof. Larry Lavery. Abstract: Are We Misdiagnosing Diabetic Foot Osteomyelitis? Is the Gold Standard Gold? – The Journal of Foot and Ankle Surgery To compare the incidence of osteomyelitis based on different operational definitions using the gold standard of bone biopsy, we prospectively […]Read More Are we misdiagnosing diabetic foot osteomyelitis? Is the gold standard…gold?
This study published from our SALSA #ToeFlowandGo group. Highlights CLTI patients had more extensive and severe disease in the infrapopliteal arteries compared to arteries above the knee. Patients with CLTI and ESRD had more severe disease in the arteries supplying flow to the plantar foot. ESRD patients exhibit a pattern of arterial disease, we termed […]Read More The “Renal Foot”: Angiographic patterns that dramatically increase challenges of limb preservation #DiabeticFoot #ActAgainstAmputation @KeckMedUSC
In this first episode of the EWMA Podcasts, Julie Jordan O’Brien and David G. Armstrong discuss current challenges and opportunities in the management and prevention of diabetic foot ulcer. Read the episode notes. HOST: Julie Jordan O’Brien is a former EWMA Council Member. She is an advanced nurse practitioner in plastic surgery at Beaumont Hospital in Ireland. GUEST: David […]Read More @USC Professor David G. Armstrong Helps to Launch First Ever @EWMAWound Podcast @KeckMedUSC #ToeFlowandGo
More than 1000 delegates from across Latin America descended upon Mexico City last week for the 2019 Endovascular Latin America Symposium (HENDOLAT). In addition to learning the latest in state-of-the art endovascular and tissue repair/lower extremity reconstruction techniques, participants were able to hear from pioneers in interdisciplinary limb preservation. This featured David G. Armstrong and […]Read More @HENDOLAT Features More than 1000 Limb Preservation Surgeons from Across the Globe – Highlighting @KeckMedUSC and @BCM_Surgery #ToeandFlow Model
Bravo to Sigal Samuel, Rafael Yuste and Vox for publishing a short, visionary start to what we hope is a broad-based discussion as we move from memory lane to the memory superhighway! 4 new rights we may need enshrined in law Several countries are already pondering how to handle “neurorights.” In Chile, two bills that […]Read More Finally? The start of a social cyber contract? Four new rights to consider in the emerging era of brain-tech
Strong work from Monge and coworkers from Torino, Italy suggest that if we focus on amputations over ulcers, we may be missing a massive public health burden– and opportunity. Incidence of hospitalization and mortality in patients with diabetic foot regardless of amputation: a population study Abstract Aims The aim of our study was to estimate […]Read More Diabetic Foot Ulcers- Not Amputations- Are Driving Hospitalizations, worldwide #DiabeticFoot #ActAgainstAmputation
Compelling work from Fields at Scripps, Florida suggest that we may be entering a new era of selective MMP inhibitors that may have profound implications from wound healing to cancer therapy. Buckle up!Read More The Rebirth of Matrix Metalloproteinase (MMP) Inhibitors?
As a very interested vascular customer at the end of the vascular peninsula, I’ve been personally fascinated with my vascular colleagues’ work in revisiting venous arterialization. To that end, about a year ago, I proposed a consortium of folks that were doing the most active thinking in the area. This included the team from Bergamo, […]Read More Lower Extremity Venous Arterialization (LEVA): Present at the Creation @HENDOLAT #DiabeticFoot #ToeFlowandGo #LEVA